Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Áø´Ü Àü¿¡ ÀÚ¹ÝÀÌ µ¿¹ÝµÇÁö ¾Ê¾Ò´ø Henoch-Schonlein ÀÚ¹Ý À§À庴ÁõÀÇ ÀÓ»óÀû °íÂû Clinical Features of Henoch-Schonlein Purpura Gastroenteropathy without Purpura before Diagnosis.

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2004³â 7±Ç 1È£ p.54 ~ 60
¿ÀÀç¹Î, ¹ÚÀçÈ«,
¼Ò¼Ó »ó¼¼Á¤º¸
¿ÀÀç¹Î ( Oh Jae-Min ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

¹ÚÀçÈ« ( Park Jae-Hong ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñ Àû: Henoch-Schonlein ÀÚ¹ÝÁõ(HSP)Àº ºñÇ÷¼ÒÆÇ °¨¼Ò¼º ÇǺΠº´º¯, °üÀýÅë ¹× °üÀý¿°, ½Å Áúȯ, »êÅ뼺 º¹ÅëÀÌ Æ¯Â¡ÀûÀÎ ¼ÒÇ÷°üÀÇ Ç÷°ü ¿°Áõ¼º ÁúȯÀÌ´Ù. ÇǺΰ¡ °¡Àå ÈçÈ÷ ħ¹üµÇ¸ç ȯÀÚÀÇ 14¡­36%¿¡¼­´Â Ư¡Àû ÇǺΠÀÚ¹ÝÀÌ ³ªÅ¸³ª±â Àü¿¡ º¹ºÎ Áõ»óÀÌ ³ªÅ¸³­´Ù°í ¾Ë·ÁÁ® ÀÖ´Ù. ÃÖ±Ù µé¾î ÇǺΠ¹ßÁøÀÌ ¾øÀÌ º¹ÅëÀ¸·Î ¹ßÇöµÇ´Â HSP¿¡ ´ëÇÑ º¸°í°¡ ÀÖÀ¸³ª, ¾ÆÁ÷±îÁö Áø´Ü¿¡ ¸¹Àº ¾î·Á¿òÀÌ ÀÖÀ¸¸ç º¸´Ù ü°èÀûÀÎ ¿¬±¸°¡ ÇÊ¿äÇÒ °ÍÀ¸·Î »ç·áµÇ¾î º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

¹æ ¹ý: 1995³â¿¡¼­ 2000³â±îÁö HSP·Î Áø´ÜµÈ ȯ¾Æ 85¸íÀ» ´ë»óÀ¸·Î Áø´Ü Àü ÇǺΠº´º¯ÀÌ ¾ø¾ú´ø ±º(ÀÚ¹Ý À½¼º±º)°ú ÀÖ¾ú´ø ±º(ÀÚ¹Ý ¾ç¼º±º)À¸·Î ±¸ºÐÇÏ°í º´·ÂÁö¸¦ ±Ù°Å·Î ÈÄÇâÀû Á¶»ç ¹× ÀϺΠ°Ë»ç¿¡ ´ëÇÑ ÀüÇâÀû ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

°á °ú: ÀÚ¹Ý ¾ç¼º±ºÀÌ 72¸í, ÀÚ¹Ý À½¼º±ºÀÌ 10¸íÀ̾ú´Ù. ÀÚ¹Ý ¾ç¼º±ºÀÇ °æ¿ì Æò±Õ ¿¬·É 6.84¼¼, ³²³àºñ 1.25£º1À̾ú°í, ÀÚ¹Ý À½¼º±ºÀÇ °æ¿ì´Â Æò±Õ ¿¬·É 7.07¼¼, ³²³àºñ 1£º1À̾ú´Ù. ÀÏ¹Ý Ç÷¾×ÇÐÀû °Ë»ç¿¡¼­ ¹éÇ÷±¸ Áõ´ÙÁõÀ̳ª Ç÷¼ÒÆÇ Áõ°¡ÁõÀÇ ºóµµ´Â µÎ ±º »çÀÌ¿¡ Åë°èÇÐÀûÀÎ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Ò´Ù(p value£¾0.05). C-¿°Áõ¼º ´Ü¹éÀÇ Áõ°¡´Â ÀÚ¹Ý ¾ç¼º±º¿¡¼­ 54.8% (34¸í), ÀÚ¹Ý À½¼º±º¿¡¼­ 42.9% (3¸í)·Î µÎ ±º »çÀÌ¿¡ ÀÇ¹Ì ÀÖ´Â Â÷ÀÌ°¡ ¾ø¾ú´Ù(p value£¾0.05). º¹ºÎ Áõ»óÀÇ °æ¿ì ¿À½É, ±¸Åä µîÀº ÀÚ¹Ý À½¼º±º¿¡¼­ 8¸í(80%), ÀÚ¹Ý ¾ç¼º±º¿¡¼­ 27¸í(36%)À¸·Î ÀÚ¹Ý À½¼º±ºÀÌ ³ôÀº ºóµµ¸¦ ³ªÅ¸³»¾úÀ¸³ª(p value=0.01), Èæ»öº¯À̳ª Ç÷º¯°ú °°Àº À§Àå°ü ÃâÇ÷À» º¸ÀÎ °æ¿ì´Â ÀÚ¹Ý ¾ç¼º±º¿¡¼­ 21¸í(29.2%), ÀÚ¹Ý À½¼º±º¿¡¼­ 4¸í(40%)À¸·Î µÎ ±º »çÀÌ¿¡ Åë°èÇÐÀûÀÎ Â÷ÀÌ°¡ ¾ø¾ú´Ù. °üÀý Áõ»óÀ̳ª ½Å ħ¹üÀÇ µ¿¹Ý ºóµµµµ ¾ç±º¿¡¼­ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Æ ÀÚ¹ÝÀ» Á¦¿ÜÇÑ ÀÓ»ó ¾ç»óÀº µÎ ±ºÀÌ ¼­·Î ºñ½ÁÇß´Ù. ÀÚ¹Ý À½¼º±ºÀÇ °æ¿ì º¹ºÎ ÃÊÀ½ÆÄ °Ë»ç ¹× ¼ÒÀå Á¶¿µ¼ú¿¡¼­ ¼ÒÀå Á¡¸·ÀÇ ºñÈÄ·Î ÀÎÇÑ º¯È­°¡ °üÂûµÇ¾ú°í, »óºÎ À§Àå°ü ³»½Ã°æÀ» ½ÃÇàÇÑ 8¸í Áß, 6¸í¿¡¼­ À¶ÇÕ¼ºÀÇ ¹Ì¶õ¼º ¹ßÀû, ºÎÁ¾, ´Ù¹ß¼º ¼±»ó ±Ë¾ç, º¸¶óºû º¯»ö µîÀÌ À§ ÀüÁ¤ºÎ ¶Ç´Â ½ÊÀÌÁöÀå ±¸ºÎ³ª µÑ°ºÎ¿¡¼­ °üÂûµÇ¾ú´Ù. 2¸í¿¡¼­´Â ´ëÀå ³»½Ã°æ °Ë»ç¸¦ ½ÃÇà, 1¸í¿¡¼­ Á÷Àå°­ ³»¿¡ ¹Ì¶õ¼ºÀÇ º´º¯À» È®ÀÎÇÏ¿´´Ù. 3¸íÀÇ È¯¾Æ¸¦ ´ë»óÀ¸·Î Á¤»ó ÇǺο¡¼­ Á¶Á÷ °Ë»ç¸¦ ½ÃÇàÇÏ¿´´Âµ¥ ¹éÇ÷±¸ Æı«¼º Ç÷°ü¿°¿¡ ÇÕ´çÇÑ ¼Ò°ßÀ» º¸¿´´Ù. ÀÚ¹Ý À½¼º±º ȯ¾Æ 10¸í Áß 9¸í¿¡¼­ ½ºÅ×·ÎÀ̵带 °æ±¸ ¶Ç´Â Á¤ÁÖÇÏ¿© Áõ»óÀÇ È£ÀüÀ» º¸¿´À¸¸ç 1¸í¿¡¼­´Â ´Ü¼ø ÁøÅëÁ¦¸¸À¸·Î Áõ»ó °æ°¨À» º¸¿´´Ù.

°á ·Ð: Áø´Ü ½Ã ÀÚ¹ÝÀÌ ¾ø¾ú´ø °æ¿ì ÀϹÝÀûÀÎ °Ë»ç¿¡¼­´Â Áø´ÜÀû ¼Ò°ßÀÌ ¾ø¾úÀ¸³ª, À§Àå°ü ³»½Ã°æ °Ë»ç¿¡¼­ HSP À§À庴Áõ¿¡ ÇÕ´çÇÑ ¼Ò°ßÀÌ °üÂûµÇ°Å³ª º¹ºÎ ÃÊÀ½ÆÄ °Ë»ç ¶Ç´Â ¼ÒÀå Á¶¿µ¼ú °Ë»ç¿¡¼­ À庮ÀÇ º¯È­, ÇǺΠ¶Ç´Â ½ÅÀå Á¶Á÷ °Ë»ç¿¡¼­ ¹éÇ÷±¸ Æı«¼º Ç÷°ü¿°ÀÌ ÀÔÁõµÉ °æ¿ì Áø´ÜÀÌ °¡´ÉÇÒ °ÍÀ¸·Î »ç·áµÈ´Ù.

Purpose:Henoch-Schonlein purpura (HSP) is a small-vessel vasculitic disease that most often affects the skin. Abdominal symptoms precede the typical purpuric rash of HSP in 14~36%. It is a challenge to diagnose HSP in the absence of a rash, because there are no biologic tests that can identify HSP with certainty, so we tried to find out the characteristic features of HSP gastroenteropathy without purpura before diagnosis.

Methods:This study included 82 children with HSP who had been admitted or visited outward of the Department of Pediatrics, Pusan National University Hospital from 1995 to 2000. The cases that the onset of purpura preceded or coincided that of abdominal pain were defined as purpura-positive group. The cases that the onset of abdominal pain preceded purpura more than 1 week and purpura was not presented till diagnosed as HSP gastroenteropathy were defined as purpura-negative group. We compared and analyzed the clinical features of the two groups by reviewing the medical records retrospectively. To ensure the diagnosis of HSP gastroenteropathy, we conducted upper GI series, abdominal ultrasonogram, abdominal CT, endoscopy and/or skin biopsy.

Results:The number of cases of purpura-positive group and purpura-negative group were 72 and 10, respectively. There is no difference between two groups in the incidence of clinical symptoms and laboratory findings. Children with HSP gastroenteropathy had characteristic erosive or ulcerative lesions in the stomach or duodenum on esophagogastroduodenoscopy, or mural thickening of the small bowel on abdominal ultrasonogram, CT or upper GI series. Skin biopsy revealed leukocytoclastic vasculitis in 3 of them, although biopsy specimen was taken from any areas of normal-appearing skin. In purpura-negative group, 9 patients improved by steroid therapy.

Conclusion:In purpura-negative group, there is no diagnostic feature on the laboratory findings and clinical features. Therefore, to diagnose HSP gastroenteropathy in patients with abdominal pain in the absence of the characteristic rash, careful observation of clinical features and laboratory data, and prompt application of available diagnostic tools such as gastrointestinal endoscopy, radiologic study and skin biopsy are recommended. Early use of corticosteroid may reduce the suffering in these patients.

Å°¿öµå

Henoch-Schonlein Purpura;Gastroenteropathy

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS